2,486
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Hypertension management during the COVID-19 pandemic: what can we learn for the future?

ORCID Icon, , , &
Pages 47-49 | Received 18 Mar 2022, Accepted 22 Mar 2022, Published online: 15 Apr 2022

References

  • Weber T, Amar J, de Backer T, et al. Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension. Blood Press. 2022.
  • Savoia C, Volpe M, Kreutz R. Hypertension, a moving target in COVID-19: current views and perspectives. Circ Res. 2021;128(7):1062–1079.
  • Kreutz R, Dobrowolski P, Prejbisz A, et al. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens. 2021;39(6):1077–1089.
  • Semenzato L, Botton J, Drouin J, et al. Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients. Hypertension. 2021;77(3):833–842.
  • Mancia G, Rea F, Ludergnani M, et al. Renin-angiotensin-aldosterone system blockers and the risk of covid-19. N Engl J Med. 2020;382(25):2431–2440.
  • Bress AP, Cohen JB, Anstey DE, et al. Inequities in hypertension control in the United States exposed and exacerbated by COVID-19 and the role of home blood pressure and virtual health care during and after the COVID-19 pandemic. J Am Heart Assoc. 2021;10(11):e020997.
  • Nguyen KH, Thorsness R, Hayes S, et al. Evaluation of racial, ethnic, and socioeconomic disparities in initiation of kidney failure treatment during the first 4 months of the COVID-19 pandemic. JAMA Netw Open. 2021;4(10):e2127369.
  • Douillet D, Dupont C, Leloup N, et al. Prevalence and characterization of forgoing care: comparison of two prospective multicentre cohorts between pre-COVID-19 era and a lockdown period. Arch Public Health. 2022;80(1):32.
  • Pengo MF, Albini F, Guglielmi G, et al. Home blood pressure during COVID-19-related lockdown in patients with hypertension. Eur J Prev Cardiol. 2021. doi:10.1093/eurjpc/zwab010.
  • Ferat LR, Forrest R, Sehmi K, et al. Preventing the next pandemic: the case for investing in circulatory health – a global coalition for circulatory health position paper. Glob Heart. 2021;16(1):66.
  • Monaco A, Casteig Blanco A, Cobain M, et al. The role of collaborative, multistakeholder partnerships in reshaping the health management of patients with noncommunicable diseases during and after the COVID-19 pandemic. Aging Clin Exp Res. 2021;33(10):2899–2907.
  • Taylor P, Berg C, Thompson J, et al. Effective access to care in a crisis period: hypertension control during the COVID-19 pandemic by telemedicine. Mayo Clin Proc Innov Qual Outcomes. 2022;6(1):19–26.
  • Williams B, Mancia G, Spiering W, et al. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36(12):2284–2309. 2018
  • Burnier M, Kjeldsen SE, Narkiewicz K, et al. Cuff-less measurements of blood pressure: are we ready for a change? Blood Press. 2021;30(4):205–207.